Mesenchymal stem cells (MSCs) are unique adult stem cells with immunosuppressive properties that also may play a key role in preventing autoimmunity. In a new study, researchers identified metabolic ...

Abstract Purpose The aim of this open-label, multicenter, randomized controlled trial was to determine the efficacy and safety of sequential umbilical cord–derived mesenchymal stem cell (UC-MSC) ...

The company states: "Mesoblast (MESO) announced the FDA approved Ryoncil, remestemcel-L, as the first mesenchymal stromal cell, MSC, therapy in the United States. RYONCIL is the only MSC therapy ...

Remestemcel-L (Ryoncil) is an allogeneic bone marrow‒derived mesenchymal stromal cell therapy for steroid-refractory acute graft-vs-host disease in pediatric patients as young as 2 months.